The BNP concentrations and exercise capacity assessment with cardiopulmonary stress test in cyanotic adult patients with congenital heart diseases

International Journal of Cardiology

Volumn 139, Issue 3, 2010, Pages 241-247

  Trojnarska, O ^a   Gwizdala, A ^a   Katarzynski, S ^a   Katarzynska, A ^a   Oko Sarnowska, Z ^a   Grajek, S ^a   Kramer, L ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

BNP level in adult patients with congenital heart disease; Cardiopulmonary exercise test; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARBON DIOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OXYGEN; SPIRONOLACTONE; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD LEVEL; CARBON DIOXIDE EXCRETION; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYANOSIS; EBSTEIN ANOMALY; EISENMENGER COMPLEX; EXERCISE TEST; FALLOT TETRALOGY; FEMALE; FORCED VITAL CAPACITY; GREAT VESSELS TRANSPOSITION; HEART RATE; HEART SINGLE VENTRICLE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; OXYGEN SATURATION; PHYSICAL CAPACITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; AGE; AGED; BLOOD; COMPARATIVE STUDY; CONGENITAL HEART MALFORMATION; EXERCISE TOLERANCE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; CYANOSIS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; YOUNG ADULT;

EID: 80052525864     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.025     Document Type: Article

References (43)

1. Perlof JK, Child JS. Congenital heart disease in adults. WB Saunders Comp. 1998.
2. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115:1039-50.
3. Oechschlin EN, Harrison DA, Connelly MS,Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol 2000;86:1111-6.
4. Engelfriet P, Boersma E, Oeschlin E. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 years follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005;26:2325-33.
5. Hijordtal VE, Stenbog EV, Ravn HB. Neurohormonal activation late after cavopulmonary connection. Heart 2000;83:439-43.
6. Bolger AP, Sharma R, Lei W. Neurohormonal activation and chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002;106:92-9.
7. Diller GP, Dimopoulos K, Okonko D. Exercise intolerance in adult congenital heart disease. Circulation 2005;112:828-35.
8. Somerville J. Grown-up congenital heart (GUCH) disease: current needs and provisions of service for adolescents and adults with congenital heart disease in UK. Heart 2002;88(suppl 1):11-4.
9. Trojnarska O, Szyszka A, Gwizdala A. Evaluation of exercise capacity with cardiopulmonary exercise testing and with type B natriuretic peptide concentration in adults patients with patent atrial septal defect. Cardiology 2006;106:154-62.
10. Fredriksen PM, Veldtman G, Hechter S. Aerobic capacity in adults with various congenital heart disease. Am J Cardiol 2001;87:310-4.
11. Diller GP, Dimopoulos K, Piepoli MF, Gatzoulis MA. Exercise intolerance in adults with congenital heart disease. Cardiol Clin 2006;24:641-60.
12. Nagaya N, Nishikimi T, Okano Y. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998;31:202-8.
13. Trojnarska O, Szyszka A, Gwizdala A. Evaluation of exercise capacity with cardiopulmonary exercise testing and with type B natriuretic peptide concentration in adults patients with patent atrial septal defect. Cardiology 2006;106:154-62.
14. Trojnarska O, Szyszka A, Gwizdala A. The BNP concentration and exercise capacity assessment with cardiopulmonary stress test in patients after surgical repair of Fallot's tetralogy. Int J Cardiol 2006;110:86-92.
15. Trojnarska O, Szyszka A, Gwizdala A. Adults with Ebstein anomaly-cardiopulmonary exercise testing and BNP level. Int J Cardiol 2006;111:92-7.
16. Trojnarska O, Gwizdala A, Łanocha M. Cardiopulmonary exercise testing in the evaluation of exercise capacity and B-type natriuretic protein level in adult patients after repair of coarctation of aorta. Texas Hart Inst J 2007;34:412-9.
17. Guidelines for the diagnosis and treatment of chronic heart failure. European Society of Cardiology. Eur Heart J 2005;26:1115-40.
18. Norozi K, Wessel A, Cand VA. Chronotropic incompetence in adolescents and adults congenital heart disease after cardiac surgery. J Card Fail 2007;13:263-8.
19. Sietsema KE, Cooper DM, Perloff JK. Dynamics of oxygen uptake during exercise in adults with cyanotic congenital heart disease. Circulation 1986;6:1137-44.
20. Dimopoulos K, Okonko DO, Diller GP. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predict survival. Circulation 2006;113:2796-802.
21. Diller GP, Dimopoulos K, Okonko D. Heart rate response during exercise predicts survival in adults with congenital heart disease. J Am Coll Cardiol 2006;48:1250-6.
22. Ohuchi H, Watanabe K, Kishiki K, Wakisako Y, Echigo S. Heart rate dynamics during and after exercise in postoperative congenital heart disease patients. Their relation to cardiac autonomic nervous activity and intrinsic sinus node dysfunction. Am Heart J 2007;154:165-71.
23. Mair J, Hammerer-Lercher A. Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39(7):571-88.
24. Book WM, Hott BJ, McConnel M. B- type natriuretic peptide levels in adults with congenital heart disease and right ventricular failure. Am J Cardiol 2005;95:545-6.
25. Yap LB. B-type natriuretic peptide and right heart. Heart Fail Rev 2004;9:99-103.
26. Oosterhof T, Tulewski II, Vliegen HW, Spijkerboer, Mudler BJM. Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of Fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and Btype natriuretic peptide levels. Am J Cardiol 2006;97:1051-5.
27. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004;25:336-40.
28. Yap LB, Ashrafian H, Mukerjee D, Coghlan JG, Timms PM. The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension. Clin Biochem 2004;37:847-56.
29. Cheung EWY, Lam WWM, Chiu CSW, Chau AKT, Cheung SCW, Cheung Y. Plasma brain natriuretic peptide levels, right ventricular volume overload and exercise capacity in adolescents after surgical repair of tetralogy of Fallot. Int J Cardiol 2007;121:155-62.
30. Larsson DA, Meurling CJ, Holmquist F, Waktere JEP, Thilen UJ. The diagnostic and prognostic value of brain natriuretic peptide in adults with a systemic morphologically right ventricle or Fontan-type circulation. Int J Cardiol 2007;114:345-51.
31. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM. Increase atrial and brain natriuretic peptides in adult patients with cyanotic congenital heart disease. Circulation 2004;109:2877-78.
32. Hopkins WE, Hall C. Paradoxical relationship between N-terminal proatrial natriuretic peptide and filling pressure in adults with cyanotic congenital heart disease. Circulation 1997;96:2215-20.
33. Lammers AE, HIslop AA, Howarth SG. Prognostic value of B-type natriuretic peptide in children with pulmonary hypertension. Int J Cardiol 2009;135:21-6.
34. Glaser S, Opitz CF, Bauer U. Assessment of symptoms and exercise capacity in cyanotic patients with congenital heart disease. Chest 2004;125:368-76.
35. 2, to exercise heperpnea in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomiopathy. Am J Cardiol 2004;93:318-23.
36. Coats AL. Heart failure: what causes the symptoms of heart failure? Heart 2001;86:574-8.
37. Perlowski AA, Aboulhosn J, Castellon Y, Miner P, Child JS. Relation of brain natriuretic peptide to myocardial performance index in adult with congenital heart disease. Am J Cardiol 2007;100:110-4.
38. Larsson DA, Meurling CJ, Holmqvist F, Waktare JEP, Thilen UJ. The diagnostic and prognostic value of brain natriuretic peptides in adults with a systemic morphologically right ventricle or Fontan-type circulation. Int J Cardiol 2007;114:345-51.
39. Hopkins WE, Waggoner AD. Severe pulmonary hypertension without right ventricle failure: the unique hearts of patients with Eisenmenger syndrome. Am J Cardiol 2002;89:34-8.
40. Lin N, Landt M, Trinlaus K, Blazer D, Kort H, Canter C. The relationship of age, haemodynamics and severity of illness with brain natriuretic peptide levels in pediatric heart disease. J Am Coll Cardiol 2004;25:341-6.
41. Book WM. Heart failure in the adult patients with congenital heart disease. J Card Fail 2005;11:306-12.
42. Dore A, Houde C, Chan KL. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricle. Circulation 2005;112:2411-6.
43. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131: 149-50.